Celcuity CELC 深 沪
已收盘 11-13 16:00:00 美东时间
64.37
+0.200
+0.31%
华盛通- 最 高64.60
- 今 开64.20
- 成交量 64.65万股
- 最 低 61.71
- 昨 收 64.17
- 总市值 31.62亿
- 52周最高 151.02
- 市盈率 静 --
- 换手率 1.32%
- 52周最低 53.54
- 委 比 89.74%
- 总股本 4912.63万
- 历史最高 151.02
- 量 比 0.74
- 振 幅 4.50%
- 历史最低 4.03
- 每 手 1
- 风险率 18.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Celcuity收跌4.07%，成交额4564.88万美元
11月12日，Celcuity（CELC）收跌4.07%，报64.32美元，成交额4564.88万美元，市值31.47亿美元。 行情数据 • 开盘价：67.9...
11-12 06:16
Block To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BTIG raised the price target for Magnite Inc (NASDAQ:MGNI) from $27 to $33. BTIG analyst Tyler DiMatteo mainta...
11-09 21:19
美股大行评级 | 巴克莱维百济神州"超配"评级！目标价从415美元上调至446美元
今日重点评级关注：瑞银：维持Liberty Media"中性"评级，目标价从110美元升至1116美元；杰富瑞：维持伊诺维奥制药"买入"评级，目标价从3美元升至8美元
11-09 14:00
Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer
Celcuity Inc. announced that the FDA has accepted its supplemental New Drug Application (sNDA) for REVTORPYK™ (gedatolisib) to treat HR+/HER2- locally advanced or metastatic breast cancer (ABC) with a <em>PIK3CA</em> mutation. The FDA assigned a PDUFA goal date of June 25, 2027. The submission is based on clinical data from the <em>PIK3CA</em> mutant cohort of the Phase 3 VIKTORIA-1 trial. If approved, REVTORPYK would become available as a second...
11-09 13:30
Guggenheim Maintains Buy on Celcuity, Lowers Price Target to $169
Guggenheim analyst Michael Schmidt maintains Celcuity (NASDAQ:CELC) with a Buy and lowers the price target from $171 to $169.
11-07 00:01
财报速睇 | Celcuity 2026财年Q3归母净利润亏损0.73亿美元，同比亏损扩大67.4%
华盛资讯11月6日讯，Celcuity公布2026财年Q3业绩，公司Q3归母净利润亏损0.73亿美元，同比亏损扩大67.4%。
11-06 06:48
财报速睇 | Celcuity 2026财年Q3归母净利润亏损0.73亿美元，同比亏损扩大67.4%
华盛资讯11月6日讯，Celcuity公布2026财年Q3业绩，公司Q3归母净利润亏损0.73亿美元，同比亏损扩大67.4%。
11-06 05:25
Celcuity收跌0.69%，成交额8200.32万美元
11月5日，Celcuity（CELC）收跌0.69%，报69.24美元，成交额8200.32万美元，市值33.88亿美元。 行情数据 • 开盘价：72美元 ...
11-05 06:15
Celcuity To Participate in Upcoming Investor Conferences
Celcuity Inc. CEO Brian Sullivan will participate in fireside chats at three investor conferences in November 2026, including Guggenheim’s Healthcare Innovation Conference, Stifel Healthcare Conference, and Jefferies Global Healthcare Conference in London. Live webcasts and replays will be available on the company’s website. Celcuity, a biotech company focused on targeted therapies for solid tumors, recently received FDA approval for REVTORPYK™ (...
11-03 13:30
Celcuity收涨2.04%，成交额7809.65万美元
10月29日，Celcuity（CELC）收涨2.04%，报69.46美元，成交额7809.65万美元，市值33.99亿美元。 行情数据 • 开盘价：67.4...
10-29 05:14
